Sclerotia Atlantis

Psilocybe atlantis: Indigenous only to Fulton County, Georgia, Psilocybe Atlantis is another relative of the magic mushroom family and has a pleasant taste and smell.

This type of sclerotia has appeared on the market and is more potent than either Tampanesis or Mexicana. Exercise caution it’s surprisingly strong compared to the other types; similar to the difference between the old Cubensis mushrooms and the Hawaiian mushrooms.

Sclerotia Psilocybe mexicana, Tampanensis and Atlantis

What is sclerotia ? 
A sclerotium (plural: sclerotia) is a hardened mass of mycelium which is more resistant to adverse environmental conditions than normal mycelium. Sclerotia form from the mycelium of certain mushroom species as a defense mechanism against dryness, cold, heat, or excessive moisture. Sclerotia contain approximately 30% dry matter. The potency of dry sclerotia is around 2/3 that of dry Psilocybe cubensis fruitbodies. 

Sclerotia Magic Mushroom Truffles

How are sclerotia grown? 
Sclerotia can be grown in vitro on rye grass seed or different grains, or harvested from spent casings of Psilocybe mexicana or Psilocybe tampanensis. Growing sclerotia in vitro is very simple and does not require any of the terrariums, air exchanges, or other complexities of fruiting mushrooms, but takes longer. Different grain substrates will work for sclerotia, but PF substrate is not suitable because of its vermiculite content. Any substrate containing materials not fit for human consumption should not be used for growing sclerotia, as it may be difficult during harvesting to separate the sclerotia from the substrate. 


What species form sclerotia? 
Psilocybe mexicana and Psilocybe tampanensis both form sclerotia, as well as Psilocybe atlantis. The 'A' strain of Psilocybe mexicana in particular is known for its exceptional sclerotia forming abilities.

Psilocybe Semilanceata USA Liberty Cap

Liberty Caps psilocybin mushrooms

Psilocybe semilanceata, commonly known as the liberty cap, is a Psychedelic or Magic Mushroom that contains the psychoactive compounds psilocybin and baeocystin. Of the world's psilocybin mushrooms, it is the most common in nature, and one of the most potent. The mushrooms have a distinctive conical to bell-shaped cap, up to 2.5 cm (1.0 in) in diameter, with a small nipple-like protrusion on the top. They are yellow to brown in color, covered with radial grooves when moist, and fade to a lighter color as they mature. Their stems tend to be slender and long, and the same color or slightly lighter than the cap. The gill attachment to the stem is adnexed (narrowly attached), and they are initially cream-colored before tinting purple as the spores mature. The spores are dark purplish-brown in mass, ellipsoid in shape, and measure 10.5–15 by 6.5–8.5 micrometers. The mushroom grows in fields, grassy meadows, and similar habitats, particularly in wet, north-facing fields (south-facing for southern hemisphere) that are well-fertilized by sheep and cattle feces. But unlike P. cubensis and P. coprophila, the fungus does not grow directly on dung; rather, it is a saprobic species that feeds off decaying grass roots. It is widely distributed in the cool temperate and subarctic regions of the Northern Hemisphere, particularly in Europe. However, it has also been reported occasionally from warmer locations such as India, South America, and Australasia. The earliest reliable history of P. semilanceata intoxication dates back to 1799 in London, and in the 1960s the mushroom was the first European species confirmed to contain psilocybin. Further investigations into the chemical makeup of the fungus revealed the presence of the substances phenylethylamine and the psychotropic baeocystin.

Psilocybe tampanensis

Psilocybe tampanensis is a very rare psychedelic mushroom in the Strophariaceae family. Originally collected in the wild in a sandy meadow near Tampa, Florida in 1977, the fungus has never again been reported in Florida, but was later collected in Mississippi. The original Florida specimen was cloned, and descendents remain in wide circulation. The fruit bodies (mushrooms) produced by the fungus are yellowish-brown in color with convex to conic caps up to 2.4 cm (0.9 in) in diameter atop a thin stem up to 6 cm (2.4 in) long. Psilocybe tampanensis forms psychoactive truffle-like sclerotia that are known and sold under the nickname "philosopher's stones". The fruit bodies and sclerotia are consumed by some for recreational or entheogenic purposes. In nature, sclerotia are produced by the fungus as a form of protection from wildfires and other natural disasters.


Psilocybe tampanensis contains the psychedelic compounds psilocin and psilocybin, and is consumed for recreational and entheogenic purposes. The species was found to be one of the most popular psychoactive mushrooms confiscated by German authorities in a 2000 report, behind Psilocybe cubensis, Psilocybe semilanceata, and Panaeolus cyanescens. The alkaloid content in the confiscated samples ranged from not detectable to 0.19% psilocybin, and 0.01 to 0.03% psilocin. According to mycologist Michael Beug, dried fruit bodies can contain up to 1% psilocybin and psilocin; in terms of psychoactive potency, Stamets considers the mushroom "moderately to highly active".The psychoactive compounds are also present in the sclerotia: in one analysis, the levels of psilocybin obtained from sclerotia ranged from 0.31% to 0.68% by dry weight, and were dependent upon the composition of the growth medium.Sclerotia are sold under the nickname "philosopher's stones". They have been described as "resembling congealed muesli", and having a somewhat bitter taste similar to walnut. Strains existing as commercial cultivation kits sold originally in countercultural drug magazines are derived from the original fruit body found by Pollock in Florida.Methods were originally developed by Pollock, and later extended by Stamets in the 1980s to cultivate the sclerotia on a substrate of rye grass (Lolium), and on straw. Sclerotia prepared in this way take from 3 to 12 weeks to develop. Pollock was granted a US patent in 1981 for his method of producing sclerotia